Brigit Biofarmaka Teknologi Tbk. vs Bank Pan Indonesia Tbk — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp254 (market cap 172.82B, 592.2K 24h volume), while Bank Pan Indonesia Tbk trades at Rp920 (market cap 21.57T, 4.98M 24h volume). The key difference: Bank Pan Indonesia Tbk is far larger — about 124.8× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Bank Pan Indonesia Tbk is more actively traded (4.98M versus 592.2K). Which is the better fit depends on your goals.
| OBAT | PNBN | |
|---|---|---|
Market Cap | 172.82B | 21.57T |
Volume | 592.2K | 4.98M |
Lot | 5.92K | 49.78K |
Turnover | 147.05M | 4.55B |
Average Price | 248.31 | 913.41 |
Value | 147.05M | 4.55B |
Indicative Equilibrium Price | 254 | 920 |
Indicative Equilibrium Volume | 10 | 2.41K |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Bank Pan Indonesia Tbk (the Bank) was established based on Deed No. 85 dated August 17, 1971 of notary Juliaan Nimrod Siregar gelar Mangaradja, S.H. Panin (Pan Indonesia) Bank was established by the merger of three small private banks. It was one of the first banks to be granted a foreign exchange license in 1972.
Read more on PNBN →